Skip to main content
logo
Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.340
-0.040 (-1.18%)
At close: May 22, 2026, 4:00 PM EDT
3.380
+0.040 (1.20%)
After-hours: May 22, 2026, 7:36 PM EDT

Alvotech Revenue

Alvotech had revenue of $105.87M in the quarter ending March 31, 2026, a decrease of -20.29%. This brings the company's revenue in the last twelve months to $559.38M, down -4.48% year-over-year. In the year 2025, Alvotech had annual revenue of $586.32M with 19.74% growth.

Revenue (ttm)
$559.38M
Revenue Growth
-4.48%
P/S Ratio
1.86
Revenue / Employee
$439,439
Employees
1,279
Market Cap
1.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025586.32M96.64M19.74%
Dec 31, 2024489.68M398.25M435.56%
Dec 31, 202391.43M6.41M7.54%
Dec 31, 202285.03M48.26M131.23%
Dec 31, 202136.77M-29.84M-44.80%
Dec 31, 202066.62M34.70M108.71%
Dec 31, 201931.92M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Phibro Animal Health1.50B
Evotec SE859.03M
Collegium Pharmaceutical796.33M
Pacira BioSciences734.86M
Amphastar Pharmaceuticals720.53M
Esperion Therapeutics418.24M
Xeris Biopharma Holdings314.85M
Harrow268.68M
Revenue Rankings

ALVO News

More News